Predictive and Prognostic Performance of IHC3 Immunohistochemistry-based Molecular Subtyping in Muscle-Invasive Bladder Cancer
Céline Hardy(Queen's University), D. M. Berman(Queen's University), L Chen(Queen's University), Chandra L. Jackson(Harvard University), Gottfrid Sjödahl(Lund University), R. J. Gooding(Queen's University)
Cited by 0
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k
A Molecular Taxonomy for Urothelial Carcinoma
|Clinical Cancer Research|2012|1k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|386